BCART.BR
Price:
$0.29
Market Cap:
$27.24M
Biocartis Group NV, a molecular diagnostics company, provides diagnostic solutions enhancing clinical practice for the benefit of patients, clinicians, payers, and healthcare industry with a focus on oncology. Its proprietary molecular diagnostics Idylla platform is a real-time polymerase chain reaction system that offers molecular information that allows treatment selection and treatment progress monitoring. The company offers Idylla BRAF, KRAS, MSI, EGFR, and NRAS-BRAF mutation tests; and Idylla SARS-CoV-2/Flu/RSV panels and SARS-CoV-2 tests, as well as SeptiCyte RAPID, a rapid host-response test. It also provides research products, including MSI, KRAS, BRAF, ctEGFR, NRAS-BRAF-EGFR S492R, ...[Read more]
Industry
Medical - Diagnostics & Research
IPO Date
2015-04-27
Stock Exchange
EURONEXT
Ticker
BCART.BR
According to Biocartis Group NV’s latest financial reports and current stock price. The company's current ROE is 203.74%. This represents a change of 203.87% compared to the average of 67.05% of the last 4 quarters.
The mean historical ROE of Biocartis Group NV over the last ten years is -14.93%. The current 203.74% ROE has changed -1464.69% with respect to the historical average. Over the past ten years (40 quarters), BCART.BR's ROE was at its highest in in the December 2022 quarter at 120.90%. The ROE was at its lowest in in the December 2014 quarter at -49.06%.
Average
-14.93%
Median
-48.17%
Minimum
-170.90%
Maximum
215.89%
Discovering the peaks and valleys of Biocartis Group NV ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 125.35%
Maximum Annual ROE = 215.89%
Minimum Annual Increase = -223.37%
Minimum Annual ROE = -170.90%
Year | ROE | Change |
---|---|---|
2022 | 215.89% | 2.39% |
2021 | 210.85% | -223.37% |
2020 | -170.90% | 125.35% |
2019 | -75.84% | 37.57% |
2018 | -55.13% | 73.73% |
2017 | -31.73% | -38.24% |
2016 | -51.38% | 48.35% |
2015 | -34.63% | -22.97% |
2014 | -44.96% | -59.67% |
2013 | -111.47% | -7.68% |
The current ROE of Biocartis Group NV (BCART.BR) is less than than its 3-year, less than than its 5-year, and greater than its 10-year historical averages
3-year avg
85.28%
5-year avg
24.97%
10-year avg
-14.93%
Biocartis Group NV’s ROE is less than Mithra Pharmaceuticals SA (498.80%), greater than MDxHealth SA (-1163.85%), less than Ontex Group NV (8.33%), greater than argenx SE (-2.75%), greater than Celyad Oncology SA (-162.02%),
Company | ROE | Market cap |
---|---|---|
498.80% | $14.45M | |
-1163.85% | $85.63M | |
8.33% | $666.22M | |
-2.75% | $37.51B | |
-162.02% | $20.16M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Biocartis Group NV using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Biocartis Group NV or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is Biocartis Group NV's ROE?
How is the ROE calculated for Biocartis Group NV (BCART.BR)?
What is the highest ROE for Biocartis Group NV (BCART.BR)?
What is the 3-year average ROE for Biocartis Group NV (BCART.BR)?
What is the 5-year average ROE for Biocartis Group NV (BCART.BR)?
How does the current ROE for Biocartis Group NV (BCART.BR) compare to its historical average?